{"id":6286,"date":"2016-04-19T15:28:20","date_gmt":"2016-04-19T13:28:20","guid":{"rendered":"https:\/\/celonpharma.com\/?p=6286"},"modified":"2016-04-19T15:28:20","modified_gmt":"2016-04-19T13:28:20","slug":"another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched","status":"publish","type":"post","link":"https:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/","title":{"rendered":"Another innovative cancer project coordinated by the Celon Pharma S.A. Research and Development Centre has been launched"},"content":{"rendered":"

On 30 March this year the inaugural meeting was held for the research project: Development of modern biomarkers and development of an innovative FGFR kinase inhibitor for the treatment of neoplastic diseases \u2013 CELONKO; the meeting offered the project participants the chance to learn the main assumptions and current status of the project.<\/strong><\/p>\n

<\/p>\n

The meeting was attended by representatives of the National Research Institute for Tuberculosis and Lung Diseases in Warsaw, the Military Institute of Medicine in Warsaw, the Maria Sk\u0142odowska-Curie Institute of Oncology in Warsaw and the Medical University of Gda\u0144sk, all of which create the CELONKO project scientific consortium along with Celon Pharma S.A<\/p>\n

The objective of the CELONKO project is preclinical and clinical development of a new anti-cancer drug targeting fibroblast growth factor receptors (FGFRs). The project received funding from the National Centre for Research and Development under the STRATEGMED II programme.<\/p>\n

Aleksandra Sta\u0144czak, MD, leader of the Oncology Research Group in the Celon Pharma S.A. Research and Development Centre, responsible for coordination of the project<\/strong>: WAs a result of R&D works, a selective, small-molecule FGFR inhibitor will be created. It will be possible to use this drug in the fight against stomach cancer, bladder cancer and in treatment of squamous cell lung cancer.<\/em><\/p>\n

The consortium members’ objective will be the development of a diagnostic test for identifying patients with FGFR receptor aberrations. This will allow for selecting the patients who would benefit most from a personalised therapy based on a selective FGFR inhibitor.<\/p>\n

The treatment options we develop adopt a very innovative approach which has not been used in cancer treatment to date. The therapy we are developing will be based on a profiled therapeutic effect and will result in few adverse reactions<\/em> \u2013 promises Jerzy Pieczykolan, PhD, Head of the Preclinical Research Department in the Celon Pharma S.A Research and Development Centre<\/strong><\/p>\n

Professor Joanna Chorostowska-Wynimko, PhD, the National Research Institute for Tuberculosis and Lung Diseases in Warsaw: <\/strong>Cancer is the second largest cause of death in the world; it is a pressing health and social problem. That is why we are very happy with the opportunity to work in the CELONKO project; I am convinced that by combining the forces of science and business we have a chance to develop an innovative treatment for some forms of solid tumours. Our tasks will include searching for molecular paths and diagnostic methods; we will also be in charge of the clinical part of the project along with the consortium leader, Celon Pharma.<\/em><\/p>\n

The total cost of the project is PLN 54,717,125, of which PLN 38,613,623 is financed by the National Centre for Research and Development.<\/p>\n

\"ncbir\"<\/a> \"strategmed\"<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

On 30 March this year the inaugural meeting was held for the research project: Development of modern biomarkers and development of an innovative FGFR kinase inhibitor for the treatment of neoplastic diseases \u2013 CELONKO; the meeting offered the project participants the chance to learn the main assumptions and current status of the project.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-6286","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"\nAnother innovative cancer project coordinated by the Celon Pharma S.A. Research and Development Centre has been launched - CelonGROUP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Another innovative cancer project coordinated by the Celon Pharma S.A. Research and Development Centre has been launched - CelonGROUP\" \/>\n<meta property=\"og:description\" content=\"On 30 March this year the inaugural meeting was held for the research project: Development of modern biomarkers and development of an innovative FGFR kinase inhibitor for the treatment of neoplastic diseases \u2013 CELONKO; the meeting offered the project participants the chance to learn the main assumptions and current status of the project.\" \/>\n<meta property=\"og:url\" content=\"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/\" \/>\n<meta property=\"og:site_name\" content=\"CelonGROUP\" \/>\n<meta property=\"article:published_time\" content=\"2016-04-19T13:28:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/12\/ncbir.jpg\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/\",\"url\":\"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/\",\"name\":\"Another innovative cancer project coordinated by the Celon Pharma S.A. Research and Development Centre has been launched - CelonGROUP\",\"isPartOf\":{\"@id\":\"https:\/\/celon.group\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/12\/ncbir.jpg\",\"datePublished\":\"2016-04-19T13:28:20+00:00\",\"author\":{\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\"},\"breadcrumb\":{\"@id\":\"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/#primaryimage\",\"url\":\"https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/12\/ncbir.jpg\",\"contentUrl\":\"https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/12\/ncbir.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celon.group\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Another innovative cancer project coordinated by the Celon Pharma S.A. Research and Development Centre has been launched\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celon.group\/en\/#website\",\"url\":\"https:\/\/celon.group\/en\/\",\"name\":\"CelonGROUP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celon.group\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\",\"name\":\"Ma\u0142gorzata Siewierska\",\"url\":\"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Another innovative cancer project coordinated by the Celon Pharma S.A. Research and Development Centre has been launched - CelonGROUP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/","og_locale":"en_US","og_type":"article","og_title":"Another innovative cancer project coordinated by the Celon Pharma S.A. Research and Development Centre has been launched - CelonGROUP","og_description":"On 30 March this year the inaugural meeting was held for the research project: Development of modern biomarkers and development of an innovative FGFR kinase inhibitor for the treatment of neoplastic diseases \u2013 CELONKO; the meeting offered the project participants the chance to learn the main assumptions and current status of the project.","og_url":"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/","og_site_name":"CelonGROUP","article_published_time":"2016-04-19T13:28:20+00:00","og_image":[{"url":"https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/12\/ncbir.jpg","type":"","width":"","height":""}],"author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/","url":"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/","name":"Another innovative cancer project coordinated by the Celon Pharma S.A. Research and Development Centre has been launched - CelonGROUP","isPartOf":{"@id":"https:\/\/celon.group\/en\/#website"},"primaryImageOfPage":{"@id":"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/#primaryimage"},"image":{"@id":"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/12\/ncbir.jpg","datePublished":"2016-04-19T13:28:20+00:00","author":{"@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf"},"breadcrumb":{"@id":"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/#primaryimage","url":"https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/12\/ncbir.jpg","contentUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/12\/ncbir.jpg"},{"@type":"BreadcrumbList","@id":"http:\/\/celon.group\/en\/2016\/04\/19\/another-innovative-cancer-project-coordinated-by-the-celon-pharma-s-a-research-and-development-centre-has-been-launched\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celon.group\/en\/"},{"@type":"ListItem","position":2,"name":"Another innovative cancer project coordinated by the Celon Pharma S.A. Research and Development Centre has been launched"}]},{"@type":"WebSite","@id":"https:\/\/celon.group\/en\/#website","url":"https:\/\/celon.group\/en\/","name":"CelonGROUP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celon.group\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf","name":"Ma\u0142gorzata Siewierska","url":"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/"}]}},"_links":{"self":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/6286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/comments?post=6286"}],"version-history":[{"count":0,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/6286\/revisions"}],"wp:attachment":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/media?parent=6286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/categories?post=6286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/tags?post=6286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}